Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | G6PD | P11413 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28212988 | 0.86 | DPP7 (0.44) | CA2GSRDPP8DPP9DPP7 | |
| SCHEMBL284483 | 0.82 | CA2 (0.38) | CA2GSRCA1ALDH1A1LMNA | |
| SCHEMBL27752816 | 0.82 | MMP9 (0.38) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL31643134 | 0.78 | GSR (0.42) | CA2GSRCA1CA12CA9 | |
| SCHEMBL927264 | 0.76 | ALPI (0.46) | CA2CA1CA12CA9LMNA | |
| SCHEMBL7871559 | 0.76 | G6PD (0.41) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL7202970 | 0.76 | G6PD (0.41) | CA2CA1CA12CA9ALDH1A1 | |
| SCHEMBL7202961 | 0.76 | G6PD (0.41) | CA2CA1CA12CA9ALDH1A1 | |
| Lysine SCHEMBL30145617 | 0.76 | GSR (0.56) | GSRMMP2MMP9THRBSLC1A3 | |
| Lysine SCHEMBL6683158 | 0.76 | GSR (0.56) | GSRMMP2MMP9THRBSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7914542-B2 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | NEOTRACT, INC. (US) | 2011-03-29 | — | — | US | claimed |
| US-20090192439-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-07-30 | — | — | US | claimed |
| US-20090060977-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-03-05 | — | — | US | claimed |
| US-20090018523-A1 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2009-01-15 | — | — | US | claimed |
| EP-1887976-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | Neotract, Inc. (US) | 2008-02-20 | — | — | EP | claimed |
| US-20060276871-A1 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | EXPLORAMED NC2, INC. (US) | 2006-12-07 | — | — | US | claimed |
| WO-2006127431-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER CONDITIONS | NEOTRACT, INC. (US) | 2006-11-30 | — | — | WO | claimed |
| US-12268797-B2 | Non-cultured, partially digested, cryopreserved cartilage product | OSIRIS THERAPEUTICS, INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-12201283-B2 | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions | Teleflex Life Sciences Llc (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240216180-A1 | SYSTEM AND METHOD FOR TREATMENT OF EUSTACHIAN TUBE FROM MIDDLE EAR APPROACH | ACCLARENT, INC. | 2024-07-04 | — | — | US | disclosed |
| US-11944518-B2 | System and method for treatment of eustachian tube from middle ear approach | ACCLARENT, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| US-20240099892-A1 | EUSTACHIAN TUBE DILATION BALLOON WITH VENTILATION PATH | ACCLARENT, INC. | 2024-03-28 | — | — | US | disclosed |
| US-11864725-B2 | Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose and/or throat | ACCLARENT, INC. (US) | 2024-01-09 | — | — | US | disclosed |
| US-20060106361-A1 | Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders | ACCLARENT, INC. (US) | 2006-05-18 | — | — | US | disclosed |
| US-20060095066-A1 | Devices, systems and methods for treating disorders of the ear, nose and throat | EXPLORAMED NC1, INC. (US) | 2006-05-04 | — | — | US | disclosed |
| WO-2006020180-A2 | IMPLANTABLE DEVICES AND METHODS FOR DELIVERING DRUGS AND OTHER SUBSTANCES TO TREAT SINUSITIS AND OTHER DISORDERS | ACCLARENT, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| WO-2005117755-A2 | DEVICES, SYSTEMS AND METHODS FOR TREATING SINUSITIUS | ACCLARRENT, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050245906-A1 | Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders | EXPLORAMED NC1, INC. (US) | 2005-11-03 | — | — | US | disclosed |
| US-20050240147-A1 | Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat | EXPLORAMED II, INC. (US) | 2005-10-27 | — | — | US | disclosed |
| US-5578477-A | SCREENING FOR ANTICANCER DRUGS, SOURCE OF PURE ENZYME | ARCH DEVELOPMENT CORPORATION (US) | 1996-11-26 | — | — | US | disclosed |